medigraphic.com
Instituto Nacional de Salud Pública

2014, Number 1

<< Back Next >>

salud publica mex 2014; 56 (1)

Parents willingness to pay for a human papillomavirus vaccine to protect their adolescent daughters. Maule Region, Chile

Cerda AA, García LY, Albornoz DV

Language: Spanish
References: 27
Page: 48-55
PDF size: 244.68 Kb.


ABSTRACT

Objective. To determine the willingness to pay of parents of teenage daughters for a vaccine against human papillomavirus in the Maule Region, Chile. Materials and methods. A sample of 386 parents with daughters between 12 and 18 years old, representing the five largest cities of the Region of Maule, socioeconomically stratified. WTP was obtained using the contingent valuation method in double bounded format. Results. Parents are willing to pay an average of US$ 252.71 to vaccinate their daughters against virus, where the price and number of daughters negatively affects the probability of willingness to pay, and family income positively affects the probability. Conclusion. There is a possibility of using shared funding between the government and the parents of potential daughter to be affected by the human papillomavirus to reduce cervical cancer events.


REFERENCES

  1. Parkin DM, Bray F. The burden of HPV-related cancer. Vaccine 2006; 24:511-525.

  2. MINSAL, Ministerio de Salud de Chile. Vacuna contra el Virus del Papiloma Humano (VPH). Informe julio de 2012. [Consultado: 10 de febrero de 2013]. Disponible en: http://www.minsal.gob.cl/portal/url/item/c9098adc64e7bccae040010165013c8a.pdf

  3. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in World. Summary Report 2009. [Consultado: 12 de Julio de 2012]. Disponible en: www. who. int/ hpvcentre

  4. Abarca K, Valenzuela MT, Vergara R, Luchsinger V, Muñoz A, Jiménez-de la Jara J, et al. Comité Consultivo de Inmunizaciones, Sociedad Chilena de Infectología. Declaración del Comité Consultivo de Inmunizaciones de la SOCHINF respecto a la vacuna antivirus papiloma humano, Septiembre 2008. Rev Med Chile 2008;136:1485-1492.

  5. Palacio-Mejia L, Rangel-Gomez G, Hernandez-Avila M, Lazcano-Ponce E. Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico. Salud Publica Mex 2003; 45 (suppl 3):315-325.

  6. Sepulveda P, González F, Napolitano C, Rancone E, Cavada G. Cáncer de cuello uterino: sobrevida a 3 y 5 años en Hospital San José. Rev Chil Obstet Ginecol 2008;73;(3):151-154.

  7. Lazcano-Ponce E, Herrero R, Munoz N, Hernández-Avila M, Salmeron J, Leyva A, et al. High prevalenceof human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples. Sex Transm Dis 2001;28:277-280.

  8. MINSAL. Sistematización de la Información sobre Cáncer Cérvico Uterino en Chile: Revisión y Análisis de Estudios de Costo-efectividad de la Vacuna contra VPH. ISBN: 978-956-8823-96-2 Registro Propiedad Intelectual. 202.390. Chile: MINSAL, 2011.

  9. Cerda A, García L, Gaete F, Pizarro T. Disposición a pagar por vacunas contra el Virus papiloma humano en la Región Metropolitana de Santiago de Chile. Rev Med de Chile 2013;141(2):167-172.

  10. Techakehakij W, Feldman RD. Cost-effectiveness of HPV vaccination compared with Pap smear screening on a national scale: a literature review. Vaccine 2008; 26(49):6258-6265.

  11. Marra F, Cloutier K, Oteng B, Marra C, Ogilvie G. Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review. Pharmacoeconomics 2009; 27(2):127-147.

  12. Armstrong E. Prophylaxis of cervical cancer and related cervical disease: a review of the costeffectiveness of vaccination against oncogenic HPV types. J Manage Care Pharm 2010; 16(3):217-230.

  13. Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Lower Gen Tract Dis 2004;8:188-194.

  14. Zimet GD, Mays RM, Winston Y, Kee R, Dickes J, Su L. Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med 2000;9:47-50.

  15. Brown D, Johnson Fr, Poulos C, Messonnier M. Mothers’ preferences and willingness to pay for vaccinating daughters against human papillomavirus. Vaccine 2010; 28:1702-1708.

  16. Cooper J. Optimal bid selection for dichotomous choice contingent valuation surveys. J Environ Econ Manage 1993;24:25-40.

  17. Hanemann M. Welfare evaluation in contingent valuation experiments with discrete responses. Am J Agric Econ 1984;66:222-241.

  18. Vásquez F, Cerda A, Orrego S. Valoración económica del ambiente. Buenos Aires, Argentina: Thomson Learning, 2007.

  19. Hanemann M, Loomis J, Kanninen B. Statistical efficiency of double-bounded dichotomous choice contingent valuation. Am J Agric Econ 1991;73(1):1255-1263.

  20. Judge G, Hill C, Griffiths W, Lutkepohl H, Lee T. Introduction to the theory and practice of econometrics. New York: John Wiley & Sons, 1988.

  21. Cooper J, Hellerstein D. CVM A Collection of Dichotomous Choice and Double-Bounded CVM Related Routines. Washington DC: USDA/NRS/Resources and Technology Division, 1994.

  22. Park T, Loomis JB, Creel. Confidence intervals for evaluating benefit estimates from dichotomous choice contingent valuation studies. Land Economics 1991;67:64-73.

  23. Barozet E, Espinoza V, Holz R, Sepúlveda D. Estratificación social en regiones: ¿qué oportunidades ofrecen las regiones en Chile?. [monografía en internet]. Chile: Subsecretaría de Desarrollo Regional y Administrativo, 2009. [consultado 2012 junio]. Disponible en: http://www.subdere.gov.cl/sites/default/noticiasold/articles-82941_recurso_4.pdf Proyecto Desigualdades: Tendencias y Procesos emergentes en la estratificación social, 2009;1-79.

  24. CONASIDA. Estudio “Genotipificación del Virus Papiloma Humano en consultantes de los centros de enfermedades de transmisión sexual (CETS) con diagnóstico de Condiloma Acuminado”. Santiago, Chile: MINSAL, 2007.

  25. Wordsworth S, Ryan M, Waugh N. Cost and benefits of cervical screening IV: valuation by women of the cervical screening programme. Cytopathology 2001;12(6):367-376.

  26. PNUD. Reducción de la pobreza. [Consultado: 13 de abril de 2012]. Disponible en: http://www.pnud.cl/areas/ReduccionPobreza/datos-pobreza-en-Chile.asp.

  27. Meza M, Carreño J, Morales F, Aranda C, Sanchez C, Espíndola J. Condición emocional de las pacientes con infección por virus del pailoma humano. Perinatol Reprod Hum 2008; 22(3):168-173.




2020     |     www.medigraphic.com